PPARγ: A Critical Determinant of Body Fat Distribution in Humans and Mice
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 15 (3) , 81-85
- https://doi.org/10.1016/j.tcm.2005.04.002
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- PPARs and the complex journey to obesityNature Medicine, 2004
- Analysis of the Relationship between PPAR-γ 2 Gene Variants and Severe Insulin Resistance in Obese Patients with Impaired Glucose ToleranceExperimental and Clinical Endocrinology & Diabetes, 2003
- A War on Obesity, Not the ObeseScience, 2003
- Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Inhibition of Cardiac Hypertrophy In Vitro and In VivoCirculation, 2002
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weightBMC Genomic Data, 2002
- Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin SystemHypertension, 2000
- Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertensionNature, 1999
- PPARγ Is Required for Placental, Cardiac, and Adipose Tissue DevelopmentPublished by Elsevier ,1999
- A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivityNature Genetics, 1998